Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emily Zhi-Yun Keung"'
Autor:
Emily Zhi-Yun Keung, Elise F Nassif, Heather Y. Lin, Alexander J. Lazar, Keila E Torres, Wei-Lien Wang, Beverly Ashleigh Guadagnolo, Andrew Justin Bishop, Kelly Hunt, Barry W. Feig, Justin E. Bird, Valerae O. Lewis, Ravin Ratan, Shreyaskumar Patel, Monika Zelazowska, Bin Liu, Kevin McBride, Jennifer Ann Wargo, Christina Lynn Roland, Neeta Somaiah
Publikováno v:
Journal of Clinical Oncology. 40:LBA11501-LBA11501
LBA11501 Background: We conducted a randomized, phase II non-comparative trial evaluating the efficacy of neoadjuvant ICB [nivolumab or ipilimumab/nivolumab] in patients (pts) with surgically resectable retroperitoneal DDLPS or extremity/truncal UPS
Autor:
Elise F Nassif, Manoj Chelvanambi, Lili Chen, Chia-Chin Wu, Ashish Damania, Emily Zhi-Yun Keung, Russell G. Witt, Michael White, Nadim J. Ajami, Matthew C. Wong, Neeta Somaiah, Boris Sepesi, Sreyashi Basu, James Patrick Allison, Padmanee Sharma, Kevin McBride, Wolf-Hervé Fridman, Jennifer Ann Wargo, Tina Cascone, Christina Lynn Roland
Publikováno v:
Journal of Clinical Oncology. 40:2511-2511
2511 Background: While ICB has significantly improved clinical outcomes across several cancer types, only 15-20% of patients develop a durable response. Thus, novel and targetable biomarkers are needed. There is increased appreciation of the role of
Autor:
Samuel Cass, Russell G. Witt, Xialong Meng, Pranoti Sahasrabhojane, Roland L. Bassett, Samuel Shelburne, Hsiu Yin Chang, Kinjal Somaiya, Kristi Mungovan, Sarah B. Fisher, Anthony Lucci, Jeffrey Edwin Lee, Merrick I. Ross, Jeffrey E. Gershenwald, Sheila Duncan, Nadim J. Ajami, Christina Lynn Roland, Jennifer Ann Wargo, Emily Zhi-Yun Keung
Publikováno v:
Journal of Clinical Oncology. 40:TPS9602-TPS9602
TPS9602 Background: Preoperative antibiotic prophylaxis is commonly used to reduce surgical site infections (SSIs). However, the rate of SSIs following surgical procedures classified as clean is only 2-3%. Overuse of antibiotics is associated with se
Autor:
Heather G. Lyu, Heather A. Lillemoe, Yi-Ju Chiang, Emily Zhi-Yun Keung, Sa Thi Nguyen, Susan K. Peterson, Keila E Torres, Kelly Hunt, Barry W. Feig, Andrew Justin Bishop, Beverly Ashleigh Guadagnolo, Neeta Somaiah, Christina Lynn Roland, Christopher Scally
Publikováno v:
Journal of Clinical Oncology. 40:11544-11544
11544 Background: In SARC028, patients with undifferentiated pleomorphic sarcoma (UPS) had a 40% overall response rate to pembrolizumab. Based on this, we conducted a randomized, phase II, non-comparative trial of combination nivolumab (nivo/RT) and
Autor:
Brandon Cope, Russell G. Witt, Yi-Ju Chiang, Riyad Navroz Seervai, Sarah B. Fisher, Anthony Lucci, Jennifer Ann Wargo, Jeffrey Edwin Lee, Ahsan Saleem Farooqi, Andrew Bishop, Jeffrey E. Gershenwald, Ryan Goepfert, Michael K.K. Wong, Beverly Ashleigh Guadagnolo, Merrick I. Ross, Phyu P Aung, Deverati Mitra, Emily Zhi-Yun Keung
Publikováno v:
Journal of Clinical Oncology. 40:9576-9576
9576 Background: MCC is a rare skin cancer historically associated with poor survival rates and which is increasing in incidence. A small number of retrospective series suggest that MCCUP may be associated with better prognosis than MCCKP while other
Autor:
Elizabeth M. Burton, Timothy Woody, Isabella Claudia Glitza, Rodabe Navroze Amaria, Emily Zhi-Yun Keung, Adi Diab, Sapna Pradyuman Patel, Michael K.K. Wong, Cassian Yee, Patrick Hwu, Jennifer Leigh McQuade, Scott Eric Woodman, Michael T. Tetzlaff, Michael A. Davies, Jennifer Ann Wargo, Kunal Rai, Hussein Abdul-Hassan Tawbi
Publikováno v:
Journal of Clinical Oncology. 37:9560-9560
9560 Background: Immune checkpoint blockade (ICB) have improved survival for many pts with MM, offering durable responses in up to 35% of pts, but many have short-lived or no response ( > 40%). A potential immune escape mechanism is the subversion of